201 related articles for article (PubMed ID: 19601820)
1. Perspectives of pharmacokinetics and metabolism in drug design.
Hsieh Y
Curr Pharm Des; 2009; 15(19):2169. PubMed ID: 19601820
[No Abstract] [Full Text] [Related]
2. Metabolite identification and profiling in drug design: current practice and future directions.
Zhang Z; Zhu M; Tang W
Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
[TBL] [Abstract][Full Text] [Related]
3. Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.
Humphrey MJ; Smith DA
Xenobiotica; 1992 Jul; 22(7):743-55. PubMed ID: 1455898
[TBL] [Abstract][Full Text] [Related]
4. Modeling and mechanistic approaches for oral absorption: quality by design in action.
Yu L; Zhang X; Lionberger R
Ther Deliv; 2012 Feb; 3(2):147-50. PubMed ID: 22834193
[No Abstract] [Full Text] [Related]
5. Drug metabolism and pharmacokinetics in support of drug design.
Tang W; Lu AY
Curr Pharm Des; 2009; 15(19):2170-83. PubMed ID: 19601821
[TBL] [Abstract][Full Text] [Related]
6. March of the synthesis machines.
Sanderson K
Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
[No Abstract] [Full Text] [Related]
7. The role of hyphenated chromatography-mass spectrometry techniques in exploratory drug metabolism and pharmacokinetics.
Hsieh Y; Korfmacher W
Curr Pharm Des; 2009; 15(19):2251-61. PubMed ID: 19601826
[TBL] [Abstract][Full Text] [Related]
8. Organic chemistry in drug discovery.
MacCoss M; Baillie TA
Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
[TBL] [Abstract][Full Text] [Related]
9. Comment. Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry.
Bell JA; Tarbit MH
Xenobiotica; 1992 Jul; 22(7):735-42. PubMed ID: 1455897
[No Abstract] [Full Text] [Related]
10. Successful drug discovery.
Swinney DC
Curr Top Med Chem; 2006; 6(5):403-4. PubMed ID: 16719799
[No Abstract] [Full Text] [Related]
11. Predicting passive transport in silico--history, hype, hope.
Clark DE; Grootenhuis PD
Curr Top Med Chem; 2003; 3(11):1193-203. PubMed ID: 12769700
[TBL] [Abstract][Full Text] [Related]
12. Role of nanotechnology in pharmaceutical product development.
Devalapally H; Chakilam A; Amiji MM
J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
[TBL] [Abstract][Full Text] [Related]
13. Drug Metabolism Letters. Editorial.
Prakash C
Drug Metab Lett; 2007 Jan; 1(1):1. PubMed ID: 19356009
[No Abstract] [Full Text] [Related]
14. In vitro methods to assess drug precipitation.
Dai WG
Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
[TBL] [Abstract][Full Text] [Related]
15. Less is more: the human microdosing concept.
Garner RC
Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185
[No Abstract] [Full Text] [Related]
16. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development.
Rolan P; Atkinson AJ; Lesko LJ; ;
Clin Pharmacol Ther; 2003 Apr; 73(4):284-91. PubMed ID: 12709718
[No Abstract] [Full Text] [Related]
17. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
Bodor N; Buchwald P
J Recept Signal Transduct Res; 2001; 21(2-3):287-310. PubMed ID: 11757686
[No Abstract] [Full Text] [Related]
18. Reporting data from high-throughput screening of small-molecule libraries.
Inglese J; Shamu CE; Guy RK
Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769
[TBL] [Abstract][Full Text] [Related]
19. Biosensor profiling of molecular interactions in pharmacology.
Cooper MA
Curr Opin Pharmacol; 2003 Oct; 3(5):557-62. PubMed ID: 14559103
[TBL] [Abstract][Full Text] [Related]
20. EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.
Tucker GT; Houston JB; Huang SM
Eur J Pharm Sci; 2001 Jul; 13(4):417-28. PubMed ID: 11480400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
